Evidence map›Paper›PMID 35182757›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

Reconstruction of a large-scale outbreak of SARS-CoV-2 infection in Iceland informs vaccination strategies.

Kristjan E Hjorleifsson, Solvi Rognvaldsson, Hakon Jonsson, Arna B Agustsdottir, Margret Andresdottir, Kolbrun Birgisdottir, Ogmundur Eiriksson, Elias S Eythorsson, Run Fridriksdottir, Gudmundur Georgsson and 33 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 5 institutions in 2 countries.

Kristjan E HjorleifssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland; Department of Computing and Mathematical Sciences, California Institute of Technology, Pasadena, CA, USA.
Solvi RognvaldssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Hakon JonssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Arna B AgustsdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Margret AndresdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Kolbrun BirgisdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Ogmundur EirikssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Elias S EythorssonInternal Medicine Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Run FridriksdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Gudmundur GeorgssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Kjartan R GudmundssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Arnaldur GylfasondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Gudbjorg HaraldsdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Brynjar O JenssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Adalbjorg JonasdottideCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Aslaug JonasdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Kamilla S JosefsdottirDirectorate of Health, Reykjavik, Iceland.
Nina KristinsdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Borghildur KristjansdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Thordur KristjanssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Droplaug N MagnusdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Runolfur PalssonInternal Medicine Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Louise le RouxdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Gudrun M SigurbergsdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Asgeir SigurdssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Martin I SigurdssonFaculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland; Operative Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Gardar SveinbjornssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Emil Aron ThorarensendeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Bjarni ThorbjornssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Marianna ThordardottirDirectorate of Health, Reykjavik, Iceland.
Agnar HelgasondeCODE Genetics/Amgen Inc., Reykjavik, Iceland; Department of Anthropology, University of Iceland, Reykjavik, Iceland.
Hilma HolmdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Ingileif JonsdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Frosti JonssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Olafur T MagnussondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Gisli MassondeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Gudmundur L NorddahldeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Jona SaemundsdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Patrick SulemdeCODE Genetics/Amgen Inc., Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE Genetics/Amgen Inc., Reykjavik, Iceland; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
Daniel F GudbjartssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland.
Pall MelsteddeCODE Genetics/Amgen Inc., Reykjavik, Iceland; School of Engineering and Natural Sciences, University of Iceland, Reykjavik, Iceland. Electronic address: Pall.Melsted@decode.is.
Kari StefanssondeCODE Genetics/Amgen Inc., Reykjavik, Iceland; Faculty of Medicine, School of Health Sciences, University of Iceland, Reykjavik, Iceland.
deCODE Genetics (Iceland) · ISUniversity of Iceland · ISDirectorate of Health · ISNational University Hospital of Iceland · ISCalifornia Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe spread of SARS-CoV-2 is dependent on several factors, both biological and behavioural. The effectiveness of nonpharmaceutical interventions can be attributed largely to changes in human behaviour, but quantifying this effect remains challenging. Reconstructing the transmission tree of the third wave of SARS-CoV-2 infections in Iceland using contact tracing and viral sequence data from 2522 cases enables us to directly compare the infectiousness of distinct groups of persons.

methodsThe transmission tree enables us to model the effect that a given population prevalence of vaccination would have had on the third wave had one of three different vaccination strategies been implemented before that time. This allows us to compare the effectiveness of the strategies in terms of minimizing the number of cases, deaths, critical cases, and severe cases.

resultsWe found that people diagnosed outside of quarantine (Rˆ=1.31) were 89% more infectious than those diagnosed while in quarantine (Rˆ=0.70) and that infectiousness decreased as a function of time spent in quarantine before diagnosis, with people diagnosed outside of quarantine being 144% more infectious than those diagnosed after ≥3 days in quarantine (Rˆ=0.54). People of working age, 16 to 66 years (Rˆ=1.08), were 46% more infectious than those outside of that age range (Rˆ=0.74). DISCUSSION: We found that vaccinating the population in order of ascending age or uniformly at random would have prevented more infections per vaccination than vaccinating in order of descending age, without significantly affecting the expected number of deaths, critical cases, or severe cases.

Indexed as

COVID-19AdolescentAdultAgedDisease OutbreaksHumansIcelandMiddle AgedModels, TheoreticalSARS-CoV-2VaccinationYoung AdultCOVID-19Outbreak reconstructionSARS-CoV-2Transmission treeVaccination strategy

Identifiers

PMID35182757
PMCPMC8849849
OpenAlexW4220861626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.